Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Obstructive sleep apnea happens when something blocks part or all upper way while sleeping. The patients diaphragm and chest muscle have to work harder to open airway and pull air into the lungs. The breath can become very shallow or may even stop breathing briefly. One usually start breathing again with loud gasp, snort or body jerk. One may not sleep well, but one probably won’t know that it’s happening. The condition can also lower the flow of oxygen to the organs and may cause uneven rhythm of heart. The common symptoms of obstructive sleep apneas are daytime sleepiness or fatigue, dry mouth or sore throat when wake up, headache in morning, troubled concentrating, forgetfulness, depression or crankiness, night sweats and restless during sleep.
The Europe obstructive sleep apnea market is witnessing rapid growth during the forecast period of 2022-2028. The big pool of undiagnosed sleep apnea patients is propelling growth of Europe obstructive sleep apnea market. Favorable reimbursement and financial aid for sleep apnea devices and therapies is also boosting growth of Europe obstructive sleep apnea market. The rising awareness about the ill effects of untreated sleep apnea is also refuelling Europe obstructive sleep apnea market. However, lack of patient compliance is hindering the growth of Europe obstructive sleep apnea market.
The exclusive COVID-19 impact analysis report by axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the obstructive sleep apnea market. In addition, complete analysis of changes on the obstructive sleep apnea expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The market witnessed the growth during owing to sudden outbreak of the COVID-19 pandemic. In first quarter of 2020, companies faced some operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and adverse impact of the virus on sleep apnea patients leads to rise in the demand and production of sleep apnea devices.
_Market.jpg)
The Europe obstructive sleep apnea market is categorised by type, end users and country.
Based on type, the Europe obstructive sleep apnea market is categorised into airway clearance system, adaptive servo-ventilation, positive airway pressure device, oral appliances and oxygen devices. The oxygen devices is also contributing to the growth of Europe obstructive sleep apnea market. The growing incidences of sleep disorders is propelling growth of Europe obstructive sleep apnea market. The increasing prevalence of chronic diseases is also boosting growth of Europe obstructive sleep apnea market.
Based on end user, the Europe obstructive sleep apnea market is segmented into home care settings and hospitals and sleep laboratories. The hospitals and sleep laboratories are likely to dominate the market in 2020. The rising patient outflow is propelling growth of Europe obstructive sleep apnea market. The growing research and development activities related to sleep disorders is also boosting growth of Europe obstructive sleep apnea market.
The Europe obstructive sleep apnea market is studies for key countries such as United Kingdom, Germany, France, Italy, Spain. In which United Kingdom is anticipated to dominate the market in 2020. The rising healthcare infrastructure is propelling growth of Europe obstructive sleep apnea market. The growing awareness among individuals is also boosting growth of Europe obstructive sleep apnea market. The increasing early diagnosis is also refuelling growth of Europe obstructive sleep apnea market.
The major key players of the markets are Becton Dickinson (CareFusion Corporation), BMC Medical Co. Ltd, Braebon Medical Corporation, Cadwell Laboratories Inc., Compumedics Limited, Curative Medical Inc, Fisher & Paykel Healthcare, GE Healthcare, ImThera, Invacare Corporation, Koninklijke Philips N.V., LivaNova, Nidek Medical India, Inspire Medical System, Somnomed, Oventus Medical and Drive Devilbiss Healthcare among others.
February 2021: The Cadwell acquired Sleepmate sleep diagnostic sensors from Ambu A/S. The Sleepmate products have been providing high quality and reliable sleep diagnostic sensor solutions for more than 30 years. Cadwell is now honoured to comprise Sleepmate portfolio as an integral part of its comprehensive sleep diagnostic solutions for both in-lab and at home testing.
August 2021: ResMed had launched their new positive airway pressure device in the US to help hundreds of millions of people with sleep apnea.
September 2020: ResMed launched first CPAP Nasal Mask with memory foam. The company recently launched their first continuos positive airway pressure (CPAP) nasal mask with a memory foam cushion, the AirTouch N20. As per the company it is the softest nasal mask till date.
October 2019: ResMed Launched AirFit N30 mask, a tube-down nasal cradle CPAP mask with a front tub which is a new option for sleep apnea treatment. ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, a nasal cradle cushion which sits under nasal bridge, eliminating soreness in those areas. The masks curved cushion is designed for supplying a secured seal regardless of how the wearer sleeps or moves.
The report analyses obstructive sleep apnea (OSA) market based on type, end user and country. By type, the market is segmented into the airway clearance system, adaptive servo-ventilation, positive airway pressure device, oral appliances and oxygen devices. Based on end user, the market is bifurcated into homecare settings and hospital and sleep laboratories. The report also analyses the impact of COVID-19 on the market and it analysed that The market witnessed the growth during owing to sudden outbreak of the COVID-19 pandemic. In first quarter of 2020, companies faced some operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and adverse impact of the virus on sleep apnea patients leads to rise in the demand and production of sleep apnea devices. The report also comprised of major key players operating in the market.
Why to buy this report:
